MARKET

VCEL

VCEL

Vericel
NASDAQ
52.33
+2.77
+5.59%
After Hours: 53.38 +1.05 +2.01% 16:27 03/27 EDT
OPEN
50.25
PREV CLOSE
49.56
HIGH
52.43
LOW
50.25
VOLUME
576.79K
TURNOVER
0
52 WEEK HIGH
52.43
52 WEEK LOW
28.02
MARKET CAP
2.53B
P/E (TTM)
-782.2123
1D
5D
1M
3M
1Y
5Y
Analyst Scoreboard: 5 Ratings For Vericel
Vericel (NASDAQ:VCEL) has been analyzed by 5 analysts in the last three months. The average price target for Vericel is $51.6, with a 12-month price target of $54.00. The company is a biopharmaceutical company specialized in cell therapies for sports medicine and severe burn care markets.
Benzinga · 1d ago
Vericel Price Target Maintained With a $54.00/Share by Truist Securities
Dow Jones · 1d ago
Truist Securities Reiterates Buy on Vericel, Maintains $54 Price Target
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
TipRanks · 1d ago
Weekly Report: what happened at VCEL last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at VCEL last week (0311-0315)?
Weekly Report · 03/18 11:23
Weekly Report: what happened at VCEL last week (0304-0308)?
Weekly Report · 03/11 11:20
Weekly Report: what happened at VCEL last week (0226-0301)?
Weekly Report · 03/04 11:23
More
About VCEL
Vericel Corporation is engaged in advanced therapies for the sports medicine and severe burn care markets. The Company markets two cell therapy products and one specialty biologic product in the United States. MACI (autologous cultured chondrocytes onporcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single ormultiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The Company also holds a license for North American rights to NexoBrid (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for the removal of eschar in adults with deep partial-thickness and/or full-thickness burns.

Webull offers Vericel Corp stock information, including NASDAQ: VCEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCEL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCEL stock methods without spending real money on the virtual paper trading platform.